Global pharmacy benefit management market

Global Pharmacy Benefit Management Market Size, Share, Growth Analysis, By Services(Speciality pharmacy services, Benefit plan design & administration), By Services Provider(Insurance companies, Retail pharmacies), By Business Model(Government Health Programs, Employer-Sponsored Programs), By Application(Mail-Order Pharmacy Services, Non-Mail Pharmacy Services), By Type(Commercial Health Plans, Self-Insured Employer Plans) - Industry Forecast 2024-2031


Report ID: SQMIG45I2098 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 147 | Figures: 78

Global Pharmacy Benefit Management Market Insights

Pharmacy Benefit Management Market size was valued at USD 60.75 billion in 2019 and is poised to grow from USD 66.87 billion in 2023 to USD 144.6 billion by 2031, growing at a CAGR of 10.12% in the forecast period (2024-2031).

PBM refers to a system in which a third-party administrator oversees prescription drug programmes on behalf of health insurers, pharmacies, drug makers, and so on. This system performs critical tasks at many levels of the pharmaceutical supply chain, from financing to determining dispensing policies. PBM firms also handle generic drug replacement, negotiate drug rebates with manufacturers and pharmacies, and work on drug formulary formulation and management. As a result, they offer a variety of services, such as specialised pharmacy services, retail pharmacy services, prescription formulary management, disease management services, benefit plan design and advice, and so on.

Due to factors such as an increase in the requirement to reduce medication errors, fast regionalization of pharmacies, an increase in the geriatric population, and an increase in labour expenses, the pharmacy benefit management market is predicted to grow significantly during the forecast period. However, a lack of willingness to implement pharmacy automation technologies, as well as tight legal procedures governing client confidentiality, are impeding the expansion of the pharmacy benefit management business. On the contrary, increased awareness among pharmacists and healthcare providers about cost-cutting strategies and Pharmacy benefit management services is likely to give attractive chances for market expansion throughout the projection period.

US Pharmacy Benefit Management Market  is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Pharmacy Benefit Management Market size was valued at USD 60.75 billion in 2019 and is poised to grow from USD 66.87 billion in 2023 to USD 144.6 billion by 2031, growing at a CAGR of 10.12% in the forecast period (2024-2031).

The pharmacy benefit management market is characterised by the presence of well-established players as well as several small and medium-sized players. These manufacturers are pursuing a variety of strategies, including new product launches, product portfolio expansion, and mergers and acquisitions. Several large firms are forming multiple strategic alliances in order to increase their market share and get a competitive edge. 'Express Scripts Holding Company', 'CVS Health Corporation', 'OptumRx, Inc.', 'Prime Therapeutics LLC', 'Humana Pharmacy Solutions, Inc.', 'MedImpact Healthcare Systems, Inc.', 'Magellan Health, Inc.', 'Cigna Corporation', 'Aetna Inc.', 'Anthem, Inc.', 'UnitedHealth Group Incorporated', 'WellDyneRx, LLC', 'Navitus Health Solutions, LLC', 'PerformRx, LLC', 'EnvisionRxOptions, LLC', 'IngenioRx, Inc.', 'Argus Health Systems, Inc.', 'ScriptCare, Ltd.', 'Catalyst Rx, Inc.', 'Curascript Specialty Distribution, Inc.'

The rising prevalence of chronic diseases among the world's population is driving up demand for treatment solutions. As a result, several large pharmaceutical corporations are focusing their efforts on producing high-priced branded drugs for the treatment of chronic disorders. This has resulted in a huge increase in pharmaceutical spending in recent years. This, combined with an increase in prescription registrations in recent years for a wide variety of chronic conditions such as cardiovascular disease, chronic lung disease, and others, is driving up healthcare costs. 

Increased Use of Machine Learning to Simplify Workflow:  The increasing acceptance of PBM services among insurance companies, retail pharmacy chains, and drug manufacturers is moving service providers' preferences from traditional workflow to advanced workflow incorporating machine learning. As a result, the companies can provide a simplified supply chain, speedy mail order delivery, and service a wide number of insurance and retail pharmacy chains in a short period of time. 

Based on region, global pharmacy benefit management market is segmented into North America, Asia Pacific, Europe, Latin America and Middle East Africa. In 2022, North America dominated the global market. The presence of a large patient population covered by medical insurance, the availability of advantageous government laws for pharmacy benefit managers, and the growing number of pharmacy benefit managers in the country are all important factors contributing to the region's supremacy. According to The National Association of Insurance Commissioners report, there will be around 66 PBM businesses serving more than 270 million Americans in March 2021. During the forecast period, Canada is expected to expand at the fastest CAGR. An increase in pharmaceutical spending and a rise in prescription filings in Canada are driving up demand for these services in this country.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global pharmacy benefit management market

Product ID: SQMIG45I2098

$5,300
BUY NOW GET FREE SAMPLE